This program will present an overview of the updated 2018 criteria.
Learning objectives: (1) identify drugs to be avoided or used with caution in older adults; (2) describe the differences between the 2018 and the 2015 Beers Criteria; and (3) describe the application and intent of the Beers Criteria.
Following the recommendation of the IOM, AGS added a public comment period that occurred in parallel to its standard invited external peer review process.
In a significant departure from previous versions of the criteria, each recommendation is rated for quality of both the evidence supporting the panel’s recommendations and the strength of their recommendations.
The Beers Criteria are intended to serve as a guide for clinicians and not as a substitute for professional judgment in prescribing decisions.
The criteria may be used in conjunction with other information to guide clinicians about safe prescribing in older adults. Beers, MD, a geriatrician, first created the Beers Criteria in 1991, through a consensus panel of experts by using the Delphi method.
The purpose of this initiative was to revise and update the Beers criteria for potentially inappropriate medication use in adults 65 years and older in the United States.
Semla, MS, Pharm D, BCGP, FCCP, AGSF The American Geriatrics Society has updated the AGS Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.Drugs listed on the Beers List are categorized according to risks for bad outcomes.The tables include medications that have cautions, should be avoided, should be avoided with concomitant medical conditions, and are contraindicated and relatively contraindicated in the elderly population.The criteria were originally published in the Archives of Internal Medicine in 1991 In 2011, the American Geriatrics Society (AGS) convened an 11-member multidisciplinary panel of experts in geriatric medicine, nursing, and pharmacotherapy to develop the 2012 American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.The 2012 AGS Beers Criteria differ from previous editions in several ways.The criteria are used in geriatrics clinical care to monitor and improve the quality of care.They are also used in training, research, and healthcare policy to assist in developing performance measures and document outcomes.The Beers Criteria serve as a critical tool in in preventing adverse drug events in older adults and are an important tool for systems and individuals who seek to ensure high quality healthcare for older adults.Originally conceived of by the late Mark Beers, MD (a geriatrician), the Beers Criteria catalogue medications that place older patients at an elevated risk for adverse drug events (ADEs) due to the physiologic changes of aging and concurrent conditions.Of these potentially inappropriate drugs, 66 were considered by the panel to have adverse outcomes of high severity.This study is an important update of previously established criteria that have been widely used and cited.